US 's FDA approved first respiratory syncytial virus vaccine for use in women during pregnancy to protect baby
https://newsonair.gov.in/News?title=US-%26%2339%3bs-FDA-approved-first-respiratory-syncytial-virus-vaccine-for-use-in-women-during-pregnancy-to-protect-baby&id=466515
https://newsonair.gov.in/News?title=US-%26%2339%3bs-FDA-approved-first-respiratory-syncytial-virus-vaccine-for-use-in-women-during-pregnancy-to-protect-baby&id=466515
newsonair.gov.in
US 's FDA approved first respiratory syncytial virus vaccine for use in women during pregnancy to protect baby
The United States of America's Food and Drug Administration (FDA) has approved the first respiratory syncytial virus (RSV) vaccine for use in women during pregnancy to protect the baby.
#GS3 #science #medicine
🔵 Respiratory syncytial virus (RSV) vaccine
🔵This vaccine has been developed by Pfizer and the approval allows the vaccine to be given to women 32 to 36 weeks into pregnancy for prevention of lower respiratory tract infection and severe disease in infants until they are six months old.
🔵 The vaccine developer has said that maternal vaccination could prevent a large number of hospitalizations due to RSV.
🔵The syncytial virus is said to be a common cause of illness in children, while infants are those at the highest risk for severe disease.
🔵 Respiratory syncytial virus (RSV) vaccine
🔵This vaccine has been developed by Pfizer and the approval allows the vaccine to be given to women 32 to 36 weeks into pregnancy for prevention of lower respiratory tract infection and severe disease in infants until they are six months old.
🔵 The vaccine developer has said that maternal vaccination could prevent a large number of hospitalizations due to RSV.
🔵The syncytial virus is said to be a common cause of illness in children, while infants are those at the highest risk for severe disease.
Press Information Bureau
https://pib.gov.in/PressReleseDetailm.aspx?PRID=1951224
https://pib.gov.in/PressReleseDetailm.aspx?PRID=1951224
Government of India
Union Minister Shri Arjun Munda interacts with EMRS students at the Dr Ambedkar International Centre in New Delhi
As part of an educational visit organised by the Ministry of Tribal Affairs and NESTS on 22nd Septem
Press Information Bureau
https://pib.gov.in/PressReleseDetailm.aspx?PRID=1951181
https://pib.gov.in/PressReleseDetailm.aspx?PRID=1951181
Government of India
Indian Coast Guard signs MoU with Philippines Coast Guard on enhanced maritime cooperation; holds the first bilateral meet
In a significant step towards bolstering the bilateral cooperation between India and Philippines, In
👍1
#Chandrayaan3
#mains
Success of Chandrayaan3 and its impact on ISRO's role on world map of space.✅️
🔵Read full article here👇👇
https://pib.gov.in/PressReleseDetailm.aspx?PRID=1951148
#isro
#ARTEMIS
#Mauritius
#Chandrayaan3
#mains
Success of Chandrayaan3 and its impact on ISRO's role on world map of space.✅️
🔵Read full article here👇👇
https://pib.gov.in/PressReleseDetailm.aspx?PRID=1951148
#isro
#ARTEMIS
#Mauritius
#Chandrayaan3
🅾️August 22 #PIB and #Aakashwani news are covered above👆
👍1
What do you think, should we create separate channel for pib and air news, so that it becomes handy at the end ?
Anonymous Poll
80%
Yes
22%
No
🌒🛰️🚀Historically, 40% of moon missions have failed
👉Among robotic lander missions-like #Chandrayaan3, the failure rate is even more - 60%
🌒 Failure rates don't stop the attempt rates..... One should keep trying but with upgrading✅️
👉Among robotic lander missions-like #Chandrayaan3, the failure rate is even more - 60%
🌒 Failure rates don't stop the attempt rates..... One should keep trying but with upgrading✅️
We are about to land.......🌒🌒
🇮🇳🇮🇳🇮🇳🇮🇳🇮🇳🇮🇳
🇮🇳🇮🇳🇮🇳🇮🇳🇮🇳🇮🇳
❤7👍1